HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GSK 1004723

structure in first source

Also Known As:

GSK-1004723; GSK1004723

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - GSK 1004723: 2
  - Pyridazines: 11
    - Phthalazines: 7
      - GSK 1004723: 2

Experts

1.	Ambery, Claire: 1 article (01/2012)
2.	Daley-Yates, Peter: 1 article (01/2012)
3.	McQuade, Barbara: 1 article (01/2012)
4.	Oliver, Amanda: 1 article (01/2012)
5.	Sweeney, Lisa: 1 article (01/2012)
6.	Watson, Joanna: 1 article (01/2012)
7.	Browning, C: 1 article (11/2011)
8.	Clark, K L: 1 article (11/2011)
9.	Connor, H E: 1 article (11/2011)
10.	Ford, A J: 1 article (11/2011)

Related Diseases

1.

Allergic Rhinitis

01/01/2012 - "Single-dose intranasal suspensions of GSK1004723 (220, 1,100 μg) failed to demonstrate clinically significant attenuation of symptoms of allergic rhinitis induced in the ECC. "
11/01/2011 - "GSK1004723 is a potent and selective histamine H(1) and H(3) receptor antagonist with a long duration of action and represents a potential novel therapy for allergic rhinitis."

Related Drugs and Biologics

1.	Suspensions
2.	Histamine (Histamine Dihydrochloride)

Related Therapies and Procedures

1.	Therapeutics